There has been some selling insider activity on Medtronic plc. Ordinary Shares (NYSE:MDT) recently. Kendall J. Powell, Director disclosed the sale of 7,907 shares of MDT stock. The shares were purchased at an average price of $85.45. Powell now owns $2,253,744 of the stock according to the SEC filing. Yesterday Chairman Omar Ishrak disclosed the sale of 61,925 shares of (MDT). The shares were sold on September 15th for an average price of $84.93. The Chairman now owns $48,063,246 of the stock per the Form 4 SEC filing.
Geoffrey Martha, EVP & GroupPres Restora Therap reported the sale of 3,766 shares. The shares were purchased at an average price of $88.26. The EVP & GroupPres Restora Therap now owns $2,318,855 of the stock according to the SEC filing.
These firms have also modified their investment in MDT. As of the end of the quarter Evercore Wealth Management, LLC had disposed of a total of 1,023 shares trimming its position 18.6%. The value of the company’s investment in Medtronic plc. Ordinary Shares decreased from $412,000 to $388,000 a change of $24,000 quarter over quarter. As of quarter end Pinkerton Retirement Specialists, LLC had bought 422 shares growing its stake by 188.4%. The value of the investment in (MDT) went from $17,000 to $41,000 increasing 141.2% for the reporting period.
Macquarie Group Ltd grew its position by buying 86,119 shares an increase of 45.2%. Macquarie Group Ltd owns 276,505 shares with a value of $23,992,000. The total value of its holdings increased 68.0%. BNP Paribas Investment Partners S.A. downsized its investment by shedding 40,050 shares a decrease of 27.3% as of 06/30/2016. BNP Paribas Investment Partners S.A. claims 106,873 shares valued at $9,273,000. The value of the position overall is down by 17.9%.
On August 26 Jefferies kept the company rating at “Buy” but raised the price expectation from $89.00 to $100.00. On June 9, 2016 Guggenheim Securities added the stock to its research portfolio setting a rating of “Neutral”.
On June 1 the stock rating was downgraded from “Buy” to “Neutral” by analysts at BTIG Research. On April 25 analysts at SunTrust Robinson Humphrey starting coverage on the stock with an initial rating of “Buy”.
Equity analyst Nomura initiated coverage on MDT with a rating of “Buy” and price target of $86.00. March 2 investment analysts at JP Morgan held the company rating at “Overweight” and moved down the price target to $85.00 from $88.00.
The company is trading up since yesterday’s close of $86.67. Medtronic plc. Ordinary Shares also recently announced a dividend for shareholders to be paid on Friday October 21st, 2016. The dividend payment will be $0.430 per share for the quarter which is $1.72 annualized. This dividend represents a yeild of $1.96 which is the dividend as a percentage of the current share price. The ex-dividend date is set for Wednesday the 6th of July 2016.
Shares last traded at $86.74 which is just a bit below $86.75, the stock’s 50 day moving average and a bit higher than the 200 day moving average of $83.15. The 50 day moving average was down by -0.01% whereas the 200 day moving average was up $3.59 or +4.31%.
Medtronic plc. Ordinary Shares currently has a P/E ratio of 33.75 and market cap is 119.87B. In the latest earnings report the EPS was $2.57 and is estimated to be $4.66 for the current year with 1,381,935,000 shares outstanding. Analysts expect next quarter’s EPS to be $1.15 and the next full year EPS is projected to be $5.18.